Influenza A NP(366-374) Strain A/PR/8/35 is an H2-Db-restricted epitope from Influenza A/PR/8/35 nucleoprotein.
Influenza A NP(366-374) Strain A/PR/8/35 is a synthetic peptide fragment derived from the nucleoprotein (NP) of the Influenza A virus, specifically corresponding to amino acids 366 to 374 of the A/PR/8/35 (H1N1) strain. As a highly conserved region within the viral nucleoprotein, this peptide serves as a critical epitope for immunological studies and has become an essential tool for researchers investigating host-pathogen interactions, T-cell recognition, and viral antigen processing. The well-characterized sequence enables precise experimental design in virology, immunology, and molecular biology, supporting efforts to elucidate mechanisms of viral infection and immune response.
Epitope mapping: Researchers utilize the NP(366-374) peptide as a defined antigenic determinant to map T-cell epitopes recognized during Influenza A infection. By presenting this peptide to cytotoxic T lymphocytes (CTLs), investigators can identify specific immune cell populations responsive to the NP epitope, facilitating detailed analyses of antigen-specific T-cell repertoires. Such studies are instrumental in understanding the cellular immune landscape elicited by Influenza A and in defining immunodominant regions critical for adaptive immunity.
Immunoassay development: The peptide is widely employed in the development and validation of immunological assays, including enzyme-linked immunospot (ELISpot) and intracellular cytokine staining (ICS) protocols. Its use as a target antigen allows for the quantitative measurement of T-cell responses in experimental models or ex vivo samples, providing robust tools for evaluating vaccine-induced or infection-induced cellular immunity. The defined sequence and reproducible immunogenicity of the NP(366-374) peptide ensure consistent assay performance across different experimental settings.
Antigen presentation studies: As a model peptide, NP(366-374) is instrumental in dissecting the mechanisms of antigen processing and presentation by major histocompatibility complex (MHC) class I molecules. Researchers employ this peptide to study how viral antigens are processed within infected or antigen-presenting cells and subsequently displayed on the cell surface for recognition by CD8+ T cells. These investigations shed light on the molecular pathways governing immune surveillance and contribute to the broader understanding of host defense mechanisms against viral pathogens.
Vaccine research: The well-characterized immunogenic properties of the NP(366-374) peptide make it a valuable component in preclinical vaccine research. It is frequently used to assess the efficacy of candidate vaccines in eliciting cellular immune responses, particularly those targeting conserved internal viral proteins. By incorporating this peptide into immunization protocols or challenge studies, researchers can evaluate the generation, specificity, and durability of T-cell responses, informing the rational design of next-generation influenza vaccines.
Peptide-based functional studies: The NP(366-374) sequence also provides a versatile platform for investigating peptide-MHC interactions, T-cell receptor (TCR) specificity, and the structural determinants of immune recognition. By synthesizing analogs or modified versions of the peptide, scientists can probe the effects of sequence variation on binding affinity, TCR engagement, and immunogenicity. These functional studies enhance our understanding of immune recognition at the molecular level and support the development of novel immunotherapeutic strategies.
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More